LifeMD, Inc. (LFMD) — Financial statements
Income statement, balance sheet, and cash flow for LifeMD, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 194↓8.7% | 212↑39.3% | 153↑28.2% | 119↑28.2% | 93 | |
| Cost of Revenue | 39↑63.3% | 24↑27.3% | 19↑1.2% | 19↑3.7% | 18 | |
| Gross Profit | 155↓17.8% | 188↑41.0% | 134↑33.2% | 100↑34.0% | 75 | |
| Operating Expenses | ||||||
| R&D Expenses | 7↓22.8% | 10↑57.0% | 6↑104.0% | 3↑213.3% | 0.95 | |
| General & Administrative Expenses | 58↓20.3% | 73↑40.6% | 52↑10.1% | 47↑18.8% | 40 | |
| Selling & Marketing Expenses | 86↓16.4% | 103↑34.8% | 76↓2.4% | 78↓5.1% | 83 | |
| SG&A Expenses | 144↓18.0% | 176↑37.1% | 128↑2.2% | 125↑2.7% | 122 | |
| Other Expenses | 11↓42.7% | 19↑38.8% | 14↓10.2% | 16↑152.0% | 6 | |
| Operating Expenses | 162↓20.6% | 205↑38.1% | 148↑3.0% | 144↑11.3% | 129 | |
| Total Costs & Expenses | 202↓11.8% | 229↑36.9% | 167↑2.8% | 162↑10.4% | 147 | |
| Operating Results | ||||||
| Operating Income | -8↑52.5% | -16↓11.4% | -14↑66.7% | -43↑20.0% | -54 | |
| Depreciation & Amortization | 7↓23.0% | 9↑43.8% | 7↑506.4% | 1↑205.8% | 0.36 | |
| EBITDA | -0.36↑94.6% | -7↑15.7% | -8↑79.6% | -39↑28.5% | -54 | |
| EBIT | -8↑52.5% | -16↓11.4% | -14↑63.5% | -40↑26.9% | -54 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1↑37.6% | -2↑16.0% | -3↓103.5% | -1↑57.7% | -3 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1↓37.6% | 2↓16.0% | 3↑103.5% | 1↓57.7% | 3 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↑100.0% | -4 | 0.00 | |
| Other Income / Expenses | -3↓15.4% | -2↑25.3% | -3↓141.0% | -1↑82.7% | -7 | |
| Income Before Tax | -10↑44.4% | -18↓5.3% | -17↑61.0% | -45↑27.2% | -61 | |
| Income Tax Expense | 0.05↓88.6% | 0.40↓6.1% | 0.43↑18.7% | 0.36↑4584.4% | 0.01 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -10↑45.4% | -19↓5.0% | -18↑60.4% | -45↑26.6% | -61 | |
| Net Income from Discontinued Operations | 3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -7↑62.4% | -19↑8.3% | -21↑54.8% | -46↑25.2% | -61 | |
| Bottom-Line Net Income | -10↑53.6% | -22↑7.2% | -24↑51.3% | -49↑21.3% | -62 | |
| EPS (Basic) | -0.23↑56.6% | -0.53↑24.3% | -0.70↑55.4% | -1.57↑30.8% | -2.27 | |
| EPS (Diluted) | -0.23↑56.6% | -0.53↑24.3% | -0.70↑55.4% | -1.57↑30.8% | -2.27 | |
| Weighted Average Shares | 45↑9.5% | 41↑21.5% | 34↑9.5% | 31↑14.7% | 27 | |
| Weighted Average Diluted Shares | 45↑9.5% | 41↑21.5% | 34↑9.5% | 31↑14.7% | 27 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.